Navigation Links
Spinal Surgery and Determination Save Lioness
Date:5/28/2008

SARASOTA, Fla., May 28 /PRNewswire/ -- Olla has had some hard knocks in her life, including those that shattered her canine teeth, a legacy from one of her owners. Then, in March, the 400-pound lioness lost the use of her back legs. In many sanctuaries, this usually results in euthanasia.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080528/CLWFNS1 )

Luckily for Olla, the non-profit Big Cat Habitat and Gulf Coast Sanctuary, which rescued her five years ago, is near Dr. Anne Chauvet, a veterinary neurosurgeon and founder of Veterinary Neuro Services -- still a relatively rare specialty. Chauvet operated on a herniated disc that was compressing Olla's spinal cord and causing the paralysis. To aid in her recovery, Legacy Pools and its affiliate, Arthur Pools International of Los Angeles, donated a custom pool to help Olla regain the full use of her legs.

"Performing surgery on such a large animal is challenging," Chauvet said. "Six people carried her to the procedure rooms for a myelogram dye study of her spinal cord and the subsequent surgery. I know of only a handful of other instances where such surgeries have even been attempted on big cats." The entire procedure took about six hours, she said. The surgery and aftercare was donated, and Chauvet also searched for someone willing to provide a pool for Olla's rehabilitation.

"We knew that time was of the essence because it was important that Olla not become depressed and lose her will to live. We want to be sure she can heal and live a full life," said Pamela Evertz of Arthur Pools International, a worldwide manufacturer and distributor of portable and above ground pools.

Kay Rosaire, founder of the Big Cat Habitat, is optimistic about Olla's recovery. "She is standing and walking and trying to play," Rosaire said. "We believe the exercise in the pool will be the fastest way to rebuild muscle stre
'/>"/>

SOURCE Veterinary Neuro Services
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. TruFUSE(R) Minimally Invasive Facet Fusion Procedure Tops 3,000 Spinal Levels
2. Spinal cord research heads new $10M funding in London, Ontario
3. Spinal cord injury research hampered by animal models, says new study
4. The Future of Spine Care Has Just Gotten Better With the Use of SpineSix BioMotion Spinal System(TM)
5. Dynatronics Introduces New DynaPro Spinal Health System and X5 Turbo
6. U of M researchers identify process that may help treat Parkinsons, spinal cord injuries
7. Gel Enables Severed Spinal Cord Fibers to Regrow
8. Alberta physiologist earns top national honor for spinal cord research
9. Omega-3 Fatty Acids Protect the Spinal Cord, Heart, Brain and Eyes
10. Long-Term Data for 884 Patients Show Vertebroplasty for Osteoporotic Spinal Fractures Provides Dramatic Pain Relief, Greatly Decreases Disability
11. Physical Therapists Offer Low-Cost Solution to High-Cost Expenditures for Spinal Conditions
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:'Cipla, Tell the Truth'; AIDS Healthcare Foundation Launches New Ad Campaign 2Health News:'Cipla, Tell the Truth'; AIDS Healthcare Foundation Launches New Ad Campaign 3Health News:'Cipla, Tell the Truth'; AIDS Healthcare Foundation Launches New Ad Campaign 4Health News:'Cipla, Tell the Truth'; AIDS Healthcare Foundation Launches New Ad Campaign 5Health News:'Cipla, Tell the Truth'; AIDS Healthcare Foundation Launches New Ad Campaign 6Health News:'Cipla, Tell the Truth'; AIDS Healthcare Foundation Launches New Ad Campaign 7Health News:Authentidate Holding Corp. to Report Fourth Quarter and Fiscal 2007 Year End Results on Thursday, September 13, 2007 2Health News:Authentidate Holding Corp. to Report Fourth Quarter and Fiscal 2007 Year End Results on Thursday, September 13, 2007 3Health News:Plexus Systems Ranks in Top Third of the 2007 Inc. 5,000 with Three-Year Sales Growth of 226% 2Health News:Plexus Systems Ranks in Top Third of the 2007 Inc. 5,000 with Three-Year Sales Growth of 226% 3Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 2Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 3Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 4Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 5Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 6Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 7Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 8Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 9Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 10Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 11Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 12
Breaking Medicine Technology:Ameritox(R) Appoints Jay B. Zimmerman as Chief Operating Officer 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Bayer Consumer Care Voluntarily Recalls One Lot of Combination Package of Alka-Seltzer Plus(R) Day & Night Cold Formula Liquid Gels 2Are angiotensins involved in the hemodynamic changes of cirrhosis patients 3F 48625 1Are angiotensins involved in the hemodynamic changes of cirrhosis patients 3F 48625 2A case of cecal volvulus 48622 1Honey bee health of concern at Western Apicultural Society conference 8803 1Honey bee health of concern at Western Apicultural Society conference 8803 2Honey bee health of concern at Western Apicultural Society conference 8803 3